The goal of the NBCI Interactive Clinical Trials Portal is to offer a centralized location with critical information about how to improve the health outcomes of African-American and Latino communities. Access to such information will ensure their awareness of critical features, benefits, and challenges of what clinical trials entail.
The website particularly provides scientific facts and data-driven information that may positively influence the viewpoints of African-Americans and Latinos regarding their participation in clinical trials. The website attempts to demystify any misconceptions about clinical trials of African-Americans and/or Latinos. The website further seeks to support the understanding of African-American and Latinos about what is needed to answer questions, seek information, and approach toward gaining important insight about overall health outcomes.
In effect, the NBCI Interactive Clinical Trials Portal is poised to enhance the level of participation of African-Americans and Latinos in clinical trials and their subsequent acceptance of clinical trials as a viable option.
Faith and Medicine l Primary Care
https://blackchurchclinicaltrials.com/faith-health.php
The National Black Church Initiative (NBCI), a coalition of 150,000 African-American and Latino churches with a population of 27.7 million, focuses on eradicating racial disparities in healthcare, clinical trials, technology, education, housing, and the environment. NBCI advocates for drug therapies to improve the overall health and well-being of African-Americans and Latinos.
Therapeutic Areas of Interest to the African-American and Latino Communities: NBCI Clinical Research Approach
There are eleven (11) pillars of NBCI Clinical Research Approaches to be used:
- Cardiovascular Diseases
- Cancer: (Liver/ Kidney/ Lung ...etc)
- Diabetes
- Blood Diseases
- Genetic Disease ( Sickle Cell)
- Mental health
- Access to Care/ lifestyles/ Selfcare
- Collection of Health Data
- Alzheimer's Disease
- Rare Diseases
- Others
FDA to Require Diversity Plan for Clinical Trials
US regulatory agency is making a ‘big change’ to increase the number of participants from traditionally under-represented groups in drug testing. This will include African-Americans, Latinos, and other minoritized communities to be involved in clinical trials. The US Food and Drug Administration (FDA) will soon require researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants.
Unequal Treatment Revisited The Current State of Racial and Ethnic Disparities in Healthcare
A National Academies committee hosted a public workshop series in 2023. Speakers invited by the committee discussed the current state of racial and ethnic health care disparities in the U.S., highlighted major drivers of health care disparities, provided insight into successful and unsuccessful interventions, identified gaps in the evidence base and proposed strategies to close those gaps, and considered ways to scale and spread effective interventions to reduce racial and ethnic inequities in health care.
Read More
Grave Robbing, Black Cemeteries, and the American Medical School
An article by Allison C. Meier
Read More
